查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1927674

全球快速病原體檢測和診斷市場：產業分析、市場規模、佔有率和預測（2025-2032 年），按產品類型、技術、檢測方法、病原體類型、最終用戶、國家和地區分類

Rapid Pathogen Detection Diagnostics Market, By Product Type, By Technology, By Detection Method, By Pathogen Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年快速病原體檢測和診斷市場規模為 209.801 億美元，預計從 2025 年到 2032 年將以 4.98% 的複合年成長率成長。

快速病原體檢測和診斷是用於快速識別檢體、檢體和環境檢體中細菌、病毒和真菌病原體的檢測解決方案。對及時疾病管理、疫情控制和食品安全日益成長的需求，推動了醫療保健、製藥和食品檢測領域對快速病原體檢測和診斷的需求。開發高靈敏度、多重檢測方法具有巨大潛力，這些方法能夠在保證準確性的同時提供快速結果，這對於就地檢驗、醫院感染控制和公共衛生監測至關重要。值得關注的趨勢包括整合分子、微流體和攜帶式平台，以提高檢測速度、便攜性和易用性。然而，高昂的開發成本、複雜的檢體製備和監管障礙等挑戰限制了這些技術在資源匱乏地區和大規模銷售點檢測中的廣泛應用，這為開發更簡便、更經濟高效且高通量的診斷解決方案提供了創新機會。

快速病原體檢測和診斷市場動態

醫療保健和食品安全領域對快速準確病原體檢測的需求日益成長

在醫療保健、製藥和食品檢測領域，快速病原體檢測的重要性日益凸顯，這顯著推動了對快速病原體檢測和診斷方法的需求。這些診斷方法在預防感染傳播、保障病人安全和維護食品品質方面發揮著至關重要的作用。隨著醫院、診斷檢查室和食品生產商將快速可靠的檢測放在首位，對能夠提供快速、準確且可重複結果的診斷方法的需求也日益成長，從而降低了污染和疾病傳播的風險。就地檢驗和攜帶式診斷平台的普及進一步推動了市場需求；這些解決方案只需少量設備即可進行現場分析。此外，感染疾病爆發、食源性疾病集體爆發以及全球監測舉措的增加也促進了快速診斷方法的廣泛應用。例如，在近期流感和諾羅病毒集體爆發期間，快速檢測實現了病原體的早期識別和控制。醫院和食品檢測實驗室對多重檢測、自動化和使用者友善系統的日益普及也進一步推動了市場成長。

快速病原體檢測與診斷市場：細分分析

全球病原體快速檢測和診斷市場按產品類型、技術、檢測方法、病原體類型、最終用戶和地區進行細分。

根據產品類型，市場可分為三大類：快速檢測套組、試劑和耗材以及分析設備和儀器。在病原體快速檢測和診斷市場中，快速檢測套組因其易用性、便攜性以及能夠在醫療照護現場提供即時結果的能力而佔據首要地位，這些優勢對於疫情應對、醫院診斷和食品安全監測至關重要。試劑和耗材位居第二。它們對於分子診斷、免疫檢測和培養平台等各種檢測方式的精準檢測至關重要，能夠支援實驗室和自動化檢測流程，並確保檢測結果的可重複性和靈敏度。分析設備和儀器為高通量、自動化和多重檢測奠定了基礎，能夠加快樣本處理速度並與先進的診斷平台整合，但需要更高的資本投入和操作專業知識。總體而言，市場優先順序反映了醫療保健、食品和環境檢測應用中對病原體檢測速度、準確性和操作效率的需求。

根據技術類型，市場可分為四個細分領域：免疫檢測、分子診斷、生物感測器檢測和微流體技術。按技術類型分類，分子診斷因其高靈敏度和特異性，以及在臨床、食品和環境樣本中檢測細菌、病毒和真菌病原體的廣泛應用，在病原體快速檢測和診斷市場中佔據首要地位。免疫檢測排名第二，廣泛用於實驗室和照護現場環境中的抗原抗體檢測。它們具有穩健性、擴充性和易於整合到自動化平台的優點。生物感測器檢測緊隨其後，因其緊湊便攜的即時、無標定病原體監測功能而備受關注，尤其是在現場檢測和食品安全應用領域。微流體技術具有小型化、高通量和多重檢測的潛力，但由於開發複雜性和基礎設施要求，其應用目前受到限制。總體而言，技術優先順序反映了靈敏度、速度、易用性和對不同檢測環境的適應性。

快速病原體檢測和診斷市場—區域分析

北美在病原體快速檢測和診斷市場中主導，預計到2025年將佔全球收入的約40.9%。這主要得益於先進的醫療基礎設施、新一代診斷技術的廣泛應用以及強力的公共衛生監測項目，尤其是在美國。歐洲位居第二，其成長動力來自強勁的臨床診斷應用、監管支持以及將快速檢測整合到整個醫療系統中的努力。亞太地區是成長最快的市場，其成長動力來自感染疾病流行率的上升、中國、印度和日本醫療服務覆蓋範圍的擴大以及對照護現場和分子診斷平台投資的增加。拉丁美洲以及中東和非洲市場也逐漸擴張，這得益於診斷基礎設施的改善和政府衛生措施的推進。策略發展包括Revvity於2024年9月收購一家基於CRISPR技術的病原體檢測Start-Ups，以增強其快速檢測能力，以及透過跨國夥伴關係改善區域分銷網路和技術獲取管道。

快速病原體檢測和診斷市場—國家分析

按國家分類，美國是病原體快速檢測和診斷市場最大的貢獻者，這得益於其先進的醫療基礎設施、分子診斷和照護現場技術的廣泛應用，以及優先考慮早期病原體識別和疫情控制的強力的公共衛生監測項目。在歐洲，德國、英國和法國等國家佔據了相當大的市場佔有率，這得益於其嚴格的監管、強大的臨床實驗室網路以及旨在促進將快速診斷融入醫療保健體係以加強疾病監測和應對的國家舉措。在亞太地區，以中國、日本和印度主導的亞太地區是成長最快的市場，這主要歸功於醫療保健投資的增加、感染疾病流行率的上升以及快速檢測平台的普及，尤其是在中國的中線城市和印度。

策略性產業趨勢包括旨在增強國家層級能力的收購和合作。例如，Levity 於 2024 年收購了一家快速診斷技術供應商，從而擴展了其在美國和歐洲的病原體檢測產品組合；羅氏診斷於 2025 年與日本一家區域分銷商建立合作關係，從而加強了當地快速病原體鑑定解決方案的獲取。

目錄

第1章 快速病原體檢測與診斷市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 快速病原體檢測和診斷的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 快速病原體檢測與診斷市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 快速病原體檢測與診斷市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：快速病原體檢測和診斷的市場狀況

  • 快速病原體檢測和診斷市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 按產品類型分類的快速病原體檢測和診斷市場

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 快速檢測套組
    • 試劑和耗材
    • 分析儀/設備

8. 按技術分類的快速病原體檢測和診斷市場

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 免疫檢測
    • 分子診斷
    • 基於生物感測器的檢測
    • 微流體技術

9. 按檢測方法分類的快速病原體檢測和診斷市場

  • 概述
    • 細分市場佔有率分析：依檢測方法
    • 光學檢測
    • 螢光偵測
    • 電化學檢測
    • 橫向流動化驗

第10章 按病原體類型分類的快速病原體檢測和診斷市場

  • 概述
    • 細分市場佔有率分析：按病原體類型分類
    • 細菌病原體
    • 病毒病原體
    • 真菌病原體

第11章 快速病原體檢測和診斷市場（按最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院和診所
    • 診斷檢查室
    • 照護現場（PoC）環境
    • 食品與環境檢查室

第12章 按地區分類的快速病原體檢測和診斷市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第13章 主要供應商分析：快速病原體檢測和診斷產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Abbott Laboratories
    • Agilent Technologies
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Cepheid
    • Danaher Corporation
    • DiaSorin
    • Fujifilm Holdings
    • GenMark Diagnostics
    • Hologic
    • Illumina
    • Luminex Corporation
    • Meridian Bioscience
    • Qiagen
    • QuidelOrtho
    • Roche Diagnostics
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Others

第14章：分析師視角360度分析

簡介目錄
Product Code: ANV5967

Rapid Pathogen Detection Diagnostics Market size was valued at US$ 20,980.10 Million in 2024, expanding at a CAGR of 4.98% from 2025 to 2032.

Rapid pathogen detection diagnostics are testing solutions designed to quickly identify bacterial, viral, and fungal pathogens in clinical, food, and environmental samples. The growing need for timely disease management, outbreak control, and food safety is driving demand for rapid pathogen detection diagnostics across healthcare, pharmaceutical, and food testing sectors. Opportunities exist in developing highly sensitive, multiplexed assays that deliver fast results while maintaining accuracy, crucial for point-of-care testing, hospital infection control, and public health surveillance. A prominent trend is the integration of molecular techniques, microfluidics, and portable platforms to enhance speed, portability, and usability. However, challenges such as high development costs, complex sample preparation, and regulatory hurdles limit widespread adoption in low-resource or large-scale field testing applications, creating opportunities for innovation in simplified, cost-effective, and high-throughput diagnostic solutions.

Rapid Pathogen Detection Diagnostics Market- Market Dynamics

Rising demand for fast and accurate pathogen detection in healthcare and food safety

The growing emphasis on rapid pathogen detection across healthcare, pharmaceutical, and food testing sectors is significantly driving demand for rapid pathogen detection diagnostics, which play a critical role in preventing outbreaks, ensuring patient safety, and maintaining food quality. As hospitals, diagnostic laboratories, and food manufacturers increasingly prioritize timely and reliable testing, there is a need for diagnostics that deliver fast, accurate, and reproducible results, reducing the risk of contamination and disease spread. The trend toward point-of-care testing and portable diagnostic platforms further fuels demand, as these solutions allow on-site analysis with minimal equipment. Moreover, the rise in infectious disease incidents, foodborne outbreaks, and global surveillance initiatives is expanding the adoption of rapid diagnostics. For instance, during recent influenza and norovirus outbreaks, rapid tests enabled quicker identification and containment of pathogens. Increasing deployment of multiplexed, automated, and user-friendly systems in hospitals and food testing facilities is further accelerating market growth.

Rapid Pathogen Detection Diagnostics Market- Segmentation Analysis:

The Global Rapid Pathogen Detection Diagnostics Market is segmented on the basis of Product Type, Technology, Detection Method, Pathogen Type, End User, and Region.

The market is segmented into three categories based on product type: rapid test kits, reagents & consumables, and analyzers & instruments. Among product types, Rapid Test Kits hold the highest priority in the rapid pathogen detection diagnostics market due to their ease of use, portability, and ability to deliver immediate results at point-of-care settings, making them critical for outbreak control, hospital diagnostics, and food safety monitoring. Reagents & Consumables rank second, as they are essential for performing accurate tests across molecular, immunoassay, and culture-based platforms, supporting both laboratory and automated testing workflows, and ensuring reproducibility and sensitivity. Analyzers & Instruments follow, as they provide the infrastructure for high-throughput, automated, and multiplexed testing, enabling faster sample processing and integration with advanced diagnostic platforms, though they require higher capital investment and operational expertise. Overall, market prioritization reflects demand for speed, accuracy, and operational efficiency in pathogen detection across healthcare, food, and environmental testing applications.

The market is categorized into four segments based on technology: immunoassays, molecular diagnostics, biosensor-based detection, and microfluidics. Among technology types, Molecular Diagnostics hold the highest priority in the rapid pathogen detection diagnostics market due to their high sensitivity, specificity, and broad adoption for detecting bacterial, viral, and fungal pathogens in clinical, food, and environmental samples. Immunoassays rank second, widely used for antigen-antibody detection in both laboratory and point-of-care settings, offering robustness, scalability, and ease of integration into automated platforms. Biosensor-Based Detection follows, gaining traction for real-time, label-free pathogen monitoring in compact and portable formats, particularly in field testing and food safety applications. Microfluidics ranks next, as it enables miniaturized, high-throughput, and multiplexed testing, although adoption is currently limited by development complexity and infrastructure requirements. Overall, prioritization reflects sensitivity, speed, usability, and adaptability to diverse testing environments.

Rapid Pathogen Detection Diagnostics Market- Geographical Insights

North America dominates the rapid pathogen detection diagnostics market, accounting for around 40.9 percent of global revenue in 2025, supported by advanced healthcare infrastructure, wide adoption of next-generation diagnostic technologies, and strong public health surveillance programs, particularly in the United States. Europe holds the second-largest share, driven by robust clinical diagnostics adoption, regulatory support, and initiatives to integrate rapid testing across healthcare systems. The Asia-Pacific region is the fastest-growing market, propelled by rising infectious disease prevalence, expanding healthcare access in China, India, and Japan, and increasing investment in point-of-care and molecular diagnostic platforms. Latin America and the Middle East & Africa are also expanding gradually with enhanced diagnostic infrastructure and government health initiatives. Strategic developments include Revvity's acquisition of a CRISPR-based pathogen detection startup in September 2024 to strengthen rapid testing capabilities and cross-border partnerships that improve regional distribution and technology access.

Rapid Pathogen Detection Diagnostics Market- Country Insights

At the country level, the United States is the foremost contributor to the rapid pathogen detection diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of molecular and point-of-care technologies, and strong public health surveillance programs that prioritize early pathogen identification and outbreak control. In Europe, countries such as Germany, the United Kingdom, and France hold significant market shares, supported by stringent regulations, robust clinical laboratory networks, and national initiatives to integrate rapid diagnostics within healthcare settings, enhancing disease surveillance and response. The Asia-Pacific region, led by China, Japan, and India, is the fastest-growing market due to increasing healthcare investments, rising infectious disease prevalence, and expanding access to rapid testing platforms, particularly in tier-2 and tier-3 cities in China and across India.

Strategic industry developments include acquisitions and collaborations that strengthen country-level capabilities; for example, Revvity's acquisition of a rapid diagnostics technology provider in 2024 expanded its pathogen detection portfolio across the U.S. and Europe, and a 2025 partnership between Roche Diagnostics and regional distributors in Japan enhanced local access to rapid pathogen identification solutions.

Rapid Pathogen Detection Diagnostics Market- Competitive Landscape:

The rapid pathogen detection diagnostics market is moderately competitive, featuring global and regional players focused on technological innovation, strategic partnerships, and expanded product offerings. Leading companies include Thermo Fisher Scientific, Roche Diagnostics, bioMerieux, QIAGEN, Danaher Corporation (Cepheid), Abbott Laboratories, BD (Becton, Dickinson and Company), Eurofins Scientific, Siemens Healthineers, and Agilent Technologies, which leverage extensive R&D investment, broad distribution networks, and advanced molecular and immunoassay technologies to maintain market leadership. Strategic acquisitions and alliances are shaping competition; for example, Revvity's acquisition of a CRISPR-based pathogen detection startup in September 2024 strengthened its rapid diagnostics portfolio, and recent collaborations between Roche Diagnostics and bioMerieux in 2025 aim to co-develop integrated rapid platforms for respiratory and bloodstream pathogen detection. Product launches, platform enhancements, and cross-sector partnerships further intensify competitive differentiation as companies strive to deliver faster, more accurate, and multiplexed detection solutions.

Recent Developments:

In December 2025, Hardy Diagnostics announced a strategic partnership with NEMIS Technologies to introduce NEMIS's N-Light(TM) rapid on-site pathogen detection technology to the North American market, enabling faster, reliable pathogen testing for food safety and environmental monitoring.

In February 2024, QIAGEN launched two new QIAstat Dx syndromic testing panels in India: the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel received CDSCO regulatory approval to enable faster, accurate multiplex infectious disease diagnosis using real-time PCR on single-use cartridges.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher Corporation
  • DiaSorin
  • Fujifilm Holdings
  • GenMark Diagnostics
  • Hologic
  • Illumina
  • Luminex Corporation
  • Meridian Bioscience
  • Qiagen
  • QuidelOrtho
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Others

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Rapid Test Kits
  • Reagents & Consumables
  • Analyzers & Instruments

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Immunoassays
  • Molecular Diagnostics
  • Biosensor-Based Detection
  • Microfluidics

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032

  • Optical Detection
  • Fluorescence Detection
  • Electrochemical Detection
  • Lateral Flow Assays

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bacterial Pathogens
  • Viral Pathogens
  • Fungal Pathogens

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Point-of-Care Settings
  • Food & Environmental Testing Labs

GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rapid Pathogen Detection Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rapid Pathogen Detection Diagnostics Market Snippet by Product Type
    • 2.1.2. Rapid Pathogen Detection Diagnostics Market Snippet by Technology
    • 2.1.3. Rapid Pathogen Detection Diagnostics Market Snippet by Detection Method
    • 2.1.4. Rapid Pathogen Detection Diagnostics Market Snippet by Pathogen Type
    • 2.1.5. Rapid Pathogen Detection Diagnostics Market Snippet by End User
    • 2.1.6. Rapid Pathogen Detection Diagnostics Market Snippet by Country
    • 2.1.7. Rapid Pathogen Detection Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Rapid Pathogen Detection Diagnostics Key Market Trends

  • 3.1. Rapid Pathogen Detection Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rapid Pathogen Detection Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rapid Pathogen Detection Diagnostics Market Opportunities
  • 3.4. Rapid Pathogen Detection Diagnostics Market Future Trends

4. Rapid Pathogen Detection Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rapid Pathogen Detection Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Rapid Pathogen Detection Diagnostics Market Landscape

  • 6.1. Rapid Pathogen Detection Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rapid Pathogen Detection Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Rapid Test Kits
    • 7.1.3. Reagents & Consumables
    • 7.1.4. Analyzers & Instruments

8. Rapid Pathogen Detection Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Immunoassays
    • 8.1.3. Molecular Diagnostics
    • 8.1.4. Biosensor-Based Detection
    • 8.1.5. Microfluidics

9. Rapid Pathogen Detection Diagnostics Market - By Detection Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
    • 9.1.2. Optical Detection
    • 9.1.3. Fluorescence Detection
    • 9.1.4. Electrochemical Detection
    • 9.1.5. Lateral Flow Assays

10. Rapid Pathogen Detection Diagnostics Market - By Pathogen Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
    • 10.1.2. Bacterial Pathogens
    • 10.1.3. Viral Pathogens
    • 10.1.4. Fungal Pathogens

11. Rapid Pathogen Detection Diagnostics Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Point-of-Care Settings
    • 11.1.5. Food & Environmental Testing Labs

12. Rapid Pathogen Detection Diagnostics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Rapid Pathogen Detection Diagnostics Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Agilent Technologies
    • 13.2.3. Becton, Dickinson and Company
    • 13.2.4. Bio-Rad Laboratories
    • 13.2.5. Cepheid
    • 13.2.6. Danaher Corporation
    • 13.2.7. DiaSorin
    • 13.2.8. Fujifilm Holdings
    • 13.2.9. GenMark Diagnostics
    • 13.2.10. Hologic
    • 13.2.11. Illumina
    • 13.2.12. Luminex Corporation
    • 13.2.13. Meridian Bioscience
    • 13.2.14. Qiagen
    • 13.2.15. QuidelOrtho
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sekisui Diagnostics
    • 13.2.18. Siemens Healthineers
    • 13.2.19. Sysmex Corporation
    • 13.2.20. Thermo Fisher Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us